Events

Summer’s here – and was celebrated despite the rain

On July 8th, it was time again for the EUROIMMUN summer party which takes place every two years following the general meeting of shareholders. More than 1,000 employees and hundreds of stockholders and guests celebrated at the company site in Lübeck. Since weeks, people had been working hard behind the scenes to offer a divers […]

Company

Yet again a successful business year for EUROIMMUN

2015 was yet again a very satisfying year for EUROIMMUN, as announced at the Annual Meeting of Shareholders on 8 July 2016. This year, around 750 shareholders assisted the meeting, which is a new record. With an increase of 17.5%, the Group turnover exceeded the threshold of 200 million euros for the first time (amounting

Science

EUVAS study confirms efficiency of automated multiparametric immunofluorescene for detection of vasculitis-associated ANCA

Scientist of the European Vasculitis Study (EUVAS) group published the results of a recent study (Csernok et al., Autoimmunity Reviews 2016) testing the performance of two fully automated platforms for multiparametric ANCA IIFT diagnostics which combine cell substrates and monospecific antigen substrates: the EUROPLUS Granulocyte Mosaic (EUROPattern, Euroimmun AG) and CytoBead ANCA (Aklides, Medipan/Generic Assays

Scroll to Top